Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Ovarian Cancer – Current Treatment – Current Treatment: Physician Insights – Ovarian Cancer (US)
Although chemotherapy has traditionally been the cornerstone of ovarian cancer treatment, angiogenesis and PARP inhibitors have revolutionized the treatment landscape, impacting prescribing…
Colorectal Cancer – Current Treatment – Current Treatment: Physician Insights – Colorectal Cancer (US)
Chemotherapy is the backbone of treatment for colorectal cancer, but treatment in the metastatic setting has expanded with the approval of several targeted agents. Well-established targeted…
Colorectal Cancer – Current Treatment – Treatment Sequencing – Colorectal Cancer (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…
Bladder Cancer and Upper Tract Urothelial Carcinoma – Current Treatment – Treatment Sequencing – Bladder Cancer and Upper Tract Urothelial Carcinoma (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…
Bladder Cancer and Upper Tract Urothelial Carcinoma – Current Treatment – Current Treatment: Physician Insights – Bladder Cancer and Upper Tract Urothelial Carcinoma (US)
Immune checkpoint inhibitors have revolutionized the treatment of bladder cancer and upper tract urothelial carcinoma (UTUC). Merck & Co.’s Keytruda and Bristol Myers Squibb’s Opdivo, once…
